Logo image
Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: Malignant or benign pathology? Report of a case
Journal article   Peer reviewed

Gallbladder mass with a carbohydrate antigen 19-9 level in the thousands: Malignant or benign pathology? Report of a case

Tatyan Clarke, Lea Matsuoka, Nicolas Jabbour, Rodrigo Mateo, Yuri Genyk, Rick Selby, Singh Gagandeep and Gagandeep P. Singh
Surgery Today, Vol.37(4)
2007

Abstract

CA-19-9 Antigen Cholecystectomy Cholecystitis Diagnosis, Differential Granuloma Humans Male Middle Aged Tumor Markers, Biological Xanthomatosis alpha fetoprotein CA 19-9 antigen carcinoembryonic antigen piperacillin plus tazobactam abdominal pain adult article bile duct carcinoma bile duct dilatation biliary tract surgery case report cholangitis cholecystectomy cholecystitis computer assisted tomography cystic duct endoscopic retrograde cholangiopancreatography fever frozen section gallbladder carcinoma hepatojejunostomy histopathology hospital admission hospital discharge human jaundice laboratory test laparotomy liver biopsy liver injury liver metastasis male operating room sphincterotomy ultrasound
Tumor markers such as carbohydrate antigen 19-9 (CA 19-9) are commonly measured in the serum of patients with suspected pancreaticobiliary malignancies. Moderate elevations of CA 19-9 may be seen in benign disease, but levels in the thousands are indicative of malignancy. We report the case of a 64-year-old man with an elevated CA 19-9 of 5791 U/ml and radiological findings suggestive of metastatic gallbladder carcinoma. The patient underwent cholecystectomy and excision of a common bile duct stricture, with hepaticojejunostomy and liver biopsy. The final surgical pathology was consistent with xanthogranulomatous cholecystitis (XGC) and the elevated CA 19-9 returned to normal postoperatively. Thus, an elevated CA 19-9 level, even in the thousands, should not preclude patients from an operation if a mass is deemed resectable. Thorough investigation and treatment may result in a curative operation even if unresectable malignant disease is initially suspected. © 2007 Springer-Verlag.

Metrics

4 Record Views

Details

Logo image